Clinical Trials Directory

Trials / Completed

CompletedNCT05798221

Complementary Self-help Strategies for Patients With Post-COVID-19 Syndrome

Complementary Self-help Strategies for Patients With Post-COVID-19 Syndrome: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
86 (actual)
Sponsor
Universität Duisburg-Essen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Individuals affected by SARS-CoV-2 infection may subsequently be affected by the so-called post-COVID syndrome. The aim of the present study is to investigate the effects of a multimodal 10-week group program consisting of self-help strategies based on complementary medicine approaches of TEM (Traditional European Medicine), TCM (Traditional Chinese Medicine), and TIM (Traditional Indian Medicine) in addition to treatment as usual versus treatment as usual alone (no active study intervention/waiting list). Endpoints of the study include subjective quantitative and qualitative as well as objective (physician-reported) variables.

Conditions

Interventions

TypeNameDescription
BEHAVIORALComplementary self-help strategies in addition to treatment as usualThe 10-week group program consists of self-help strategies from complementary medicine approaches of TEM (Traditional European Medicine), TCM (Traditional Chinese Medicine), and TIM (Traditional Indian Medicine) in addition to treatment as usual
OTHERTreatment as usualThe active control group consists a 16-week waiting period, where treatment as usual is allowed. In case of acute worsening/progression of the symptoms, consultations with the study physician are offered anytime. After the waiting period, the control group will be offered the same units as in the experimental group.

Timeline

Start date
2023-04-25
Primary completion
2025-03-25
Completion
2025-10-06
First posted
2023-04-04
Last updated
2025-11-19

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05798221. Inclusion in this directory is not an endorsement.